A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis.

Beate Skinningsrud; Benedicte A Lie; Eystein S Husebye; Tore K Kvien; Øystein Førre; Berit Flatø; Alice Stormyr; Geir Joner; Pål R Njølstad; Thore Egeland

doi:10.1136/ard.2009.114934

A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis.

Identifier:nobleid.org/w1/20260515/0CFC4EF1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0CFC4EF1.svg?ark=w1%2F20260515%2F0CFC4EF1)](https://nobleid.org/work/w1/20260515/0CFC4EF1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis.

Identifier:nobleid.org/w1/20260515/0CFC4EF1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0CFC4EF1.svg?ark=w1%2F20260515%2F0CFC4EF1)](https://nobleid.org/work/w1/20260515/0CFC4EF1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work